MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/diagnostics12071764

Медицинская библиотека · Diagnostics (Basel, Switzerland) · 2022

Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis.

Lococo Filippo, Nachira Dania, Chiappetta Marco, Evangelista Jessica, Falcoz Pierre Emmanuel, Ruffini Enrico, Van Schil Paul, Scarci Marco, Furàk Jòzsef, Sollitto Francesco, Guerrera Francesco, Spaggiari Lorenzo, Aigner Clemens, Evangelia Liverakou, Billè Andrea, Moser Bernhard, Thomas Pascal Alexandre, Liberman Moishe, Boubia Souheil, Campisi Alessio, Ampollini Luca, Toker Alper, Enyed Attila, Voltolini Luca, Van Raemdonck Dirk, Margaritora Stefano, Ests Thymic Working Group

СтатьяПеревод пока не подготовлен

Аннотация

Background

Thymic carcinoma is a rare and highly malignant tumor with a dismal prognosis, which occasionally coexists with myasthenia gravis (MG). This study aims to investigate the MG incidence on a surgical cohort of patients with thymic carcinoma and to explore its influence on long-term survival.

Methods

the prospectively collected data from the ESTS database on thymic epithelial tumors were reviewed. Clinical, pathological, and survival information on thymic carcinoma were analyzed.

Results

the analysis was conducted on 203 patients, with an equal gender distribution (96 males and 107 females). MG was detected in 22 (10.8%) patients, more frequently elderly (>60 years, p = 0.048) and male (p = 0.003). Induction therapy was performed in 22 (10.8%) cases. After surgery, 120 (59.1%) patients had a Masaoka stage II−III while complete resection (R0) was achieved in 158 (77.8%). Adjuvant therapy was performed in 68 cases. Mean follow-up was 60 (SD = 14) months. The 3-year, 5-year and 10-year survival rates were 79%, 75% and 63%, respectively. MG did not seem to influence long-term survival (5-year survival in non-MG−TCs 78% vs. 50% in MG−TCs, p = ns) as age < 60 years, female gender, early Masaoka stage, and postoperative radiotherapy did, conversely.

Conclusions

myasthenia occurred in about 10% of thymic carcinomas and it did not seem to affect significantly the long-term prognosis in surgically treated thymic carcinoma-patients.

Для цитирования: Lococo Filippo, Nachira Dania, Chiappetta Marco, Evangelista Jessica, Falcoz Pierre Emmanuel, Ruffini Enrico, Van Schil Paul, Scarci Marco, Furàk Jòzsef, Sollitto Francesco, Guerrera Francesco, Spaggiari Lorenzo, Aigner Clemens, Evangelia Liverakou, Billè Andrea, Moser Bernhard, Thomas Pascal Alexandre, Liberman Moishe, Boubia Souheil, Campisi Alessio, Ampollini Luca, Toker Alper, Enyed Attila, Voltolini Luca, Van Raemdonck Dirk, Margaritora Stefano, Ests Thymic Working Group. Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis.. Diagnostics (Basel, Switzerland). 2022. DOI: 10.3390/diagnostics12071764.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.